Gen Xers and millennials aren't ready for the long-term care crisis their boomer parents are facing
Many millennials and Gen Xers are facing a stark reality: their parents and grandparents don't have the means to pay for long ...
health.economictimes.indiatimes6h
US proposes payment rate for 2026 Medicare Advantage insurers
The government payment rate affects how much insurers charge for monthly premiums, which plan benefits they offer and ...
JD Supra18h
Adapting to the IRA: Early Lessons Learned on the IRA’s Impact on Deal-Making, Drug Economics, and Business Strategy
More than two years after the passage of the Inflation Reduction Act (“IRA”) and the Centers for Medicare and Medicaid Services’ (“CMS’”) ...
Center on Budget and Policy Priorities22h
Growth in Medicare Advantage Raises Concerns
MA plans are substantially overpaid compared to traditional Medicare. Much of these overpayments benefit the MA plans rather ...
BioSpace23h
Part D Drugs Almost Doubled in Cost Since Launch, Underscoring Importance of IRA: AARP
Concurrently, a preprint from the industry-backed Vital Transformation found a 50% drop in company investments into ...
Medicare enrollees throughout U.S. getting relief in prescription drug costs in 2025
It’s the dawn of a new age as Medicare enrollees will be able to save a lot of money on their prescription drugs. “For those ...
Tax cuts, debt limit, spending caps: Congress faces key fiscal choices this year
The Fiscal Responsibility Act of 2023, which suspended the debt limit until last week, also established binding discretionary ...
Prices of top 25 Medicare Part D drugs have nearly doubled, AARP study finds
AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...
Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...
New AARP Report: Top Medicare Part D Drugs See Average Lifetime Price Hike of 98%
Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...
Ozempic, Trulicity among Medicare's priciest drugs, report finds
Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet ...
Drugs not selected for Medicare negotiations saw prices nearly double - report
Top Medicare Part D drugs without price negotiations have seen a 98% increase in list prices since their launch. Read more ...